Beijing Foyou Pharma Co., Ltd.SSE: 601089

Announcement on Convening the Q1 2025 Performance Briefing

Apr 25, 2025 · Issued by Beijing Foyou Pharma Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 25, 2025

On 6ix: 6ix.com/news/announcement-on-convening-the-q1-2025-performance-briefing-22

Announcement on Convening the Q1 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Beijing Foyou Pharma Co., Ltd. on 6ix

Later from Beijing Foyou Pharma

Announcement on Obtaining Drug Registration Certificate for Rosuvastatin Calcium and Ezetimibe Tablets (I)Apr 26, 2025
Announcement on Resolutions of the 2024 Annual General MeetingApr 29, 2025
Announcement on Resolutions of the 17th Meeting of the 2nd Board of DirectorsApr 30, 2025
Announcement on Resolution of the 1st Extraordinary General Meeting in 2025May 28, 2025
Announcement on the Completion of Term Change and Election of Board of Directors and Board of Supervisors and Appointment of Senior Management Members, Head of Audit Department and Securities Affairs RepresentativeMay 29, 2025

All Beijing Foyou Pharma news releases

Follow Beijing Foyou Pharma into a list and get an email when it puts out news.

Follow Beijing Foyou Pharma